Biogen Inc (BIIB)
194.44
+3.99
(+2.10%)
USD |
NASDAQ |
Apr 19, 16:00
194.44
0.00 (0.00%)
After-Hours: 20:00
Biogen Market Cap: 28.26B for April 19, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 18, 2024 | 27.68B |
| April 17, 2024 | 27.93B |
| April 16, 2024 | 28.37B |
| April 15, 2024 | 28.61B |
| April 12, 2024 | 28.81B |
| April 11, 2024 | 29.61B |
| April 10, 2024 | 29.30B |
| April 09, 2024 | 30.02B |
| April 08, 2024 | 29.79B |
| April 05, 2024 | 29.63B |
| April 04, 2024 | 29.84B |
| April 03, 2024 | 30.00B |
| April 02, 2024 | 30.18B |
| April 01, 2024 | 31.23B |
| March 28, 2024 | 31.34B |
| March 27, 2024 | 31.45B |
| March 26, 2024 | 30.82B |
| March 25, 2024 | 31.50B |
| March 22, 2024 | 31.70B |
| March 21, 2024 | 32.09B |
| March 20, 2024 | 31.71B |
| March 19, 2024 | 31.78B |
| March 18, 2024 | 31.89B |
| March 15, 2024 | 31.88B |
| March 14, 2024 | 31.92B |
| Date | Value |
|---|---|
| March 13, 2024 | 32.93B |
| March 12, 2024 | 33.05B |
| March 11, 2024 | 33.44B |
| March 08, 2024 | 32.45B |
| March 07, 2024 | 31.89B |
| March 06, 2024 | 31.62B |
| March 05, 2024 | 31.58B |
| March 04, 2024 | 32.13B |
| March 01, 2024 | 32.12B |
| February 29, 2024 | 31.54B |
| February 28, 2024 | 32.23B |
| February 27, 2024 | 32.55B |
| February 26, 2024 | 32.52B |
| February 23, 2024 | 32.46B |
| February 22, 2024 | 32.34B |
| February 21, 2024 | 32.14B |
| February 20, 2024 | 31.86B |
| February 16, 2024 | 31.85B |
| February 15, 2024 | 32.47B |
| February 14, 2024 | 32.09B |
| February 13, 2024 | 32.95B |
| February 12, 2024 | 35.58B |
| February 09, 2024 | 34.92B |
| February 08, 2024 | 34.82B |
| February 07, 2024 | 34.85B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
27.47B
Minimum
May 09 2022
62.44B
Maximum
Jun 10 2021
40.93B
Average
40.95B
Median
Dec 19 2022
Market Cap Benchmarks
| Eli Lilly and Co | 690.59B |
| Bristol-Myers Squibb Co | 98.93B |
| AbbVie Inc | 293.96B |
| Amgen Inc | 144.13B |
| Regeneron Pharmaceuticals Inc | 98.37B |
Market Cap Related Metrics
| PE Ratio | 24.37 |
| PS Ratio | 2.873 |
| Price to Book Value | 1.910 |
| Price to Free Cash Flow | 22.87 |
| Price | 194.44 |
| Earnings Yield | 4.10% |
| Operating PE Ratio | 15.43 |
| Normalized PE Ratio | 17.47 |